Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication

We evaluated the impact of pharmacist-led heart failure drug recommendations during hospitalization for hospitalized patients with HF

Masanori Suzuki

2017

Scholarcy highlights

  • We evaluated the impact of pharmacist-led heart failure drug recommendations during hospitalization for hospitalized patients with HF
  • Patients with HF with reduced ejection fraction who were not on beta blockers or angiotensin-converting enzyme inhibitor/angiotensin receptor blockers at admission were significantly more likely to be on beta blockers at the time of discharge in the intervention group compared to those in non-intervention group; the change in ACE-I/ARB prescriptions was not significant
  • The proportion of patients on any drug with recommendations against its use in patients with HF did not change from admission to discharge in the non-intervention group, but was significantly reduced in the intervention group
  • Roblek T, Deticek A, Leskovar B, Suskovic S, Horvat M, Belic A, Mrhar A, Lainscak M Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: a randomized, double-blind, controlled trial

Need more features? Save interactive summary cards to your Scholarcy Library.